A Two-Gene Signature, SKI and SLAMF1, Predicts Time-to-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia

We developed and validated a two-gene signature that predicts prognosis in previously-untreated chronic lymphocytic leukemia (CLL) patients. Using a 65 sample training set, from a cohort of 131 patients, we identified the best clinical models to predict time-to-treatment (TTT) and overall survival (...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Schweighofer, Carmen D., Coombes, Kevin R., Barron, Lynn L., Diao, Lixia, Newman, Rachel J., Ferrajoli, Alessandra, O'Brien, Susan, Wierda, William G., Luthra, Rajyalakshmi, Medeiros, L. Jeffrey, Keating, Michael J., Abruzzo, Lynne V.
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2011
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3237436/
https://ncbi.nlm.nih.gov/pubmed/22194822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0028277
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares